The size of the Contract Research Organization (CRO) Services Market in North America is anticipated to grow at a 6.02% CAGR from 2024 to 2029. It is estimated that the North American market was valued at USD 16.49 billion in 2024 and is expected to reach USD 22.08 billion by 2029.
The majority of the Americans are suffering from cardiovascular diseases providing considerable segment opportunities in the market, according to Heart Disease and Stroke Statistics, 2017. Growing investments in healthcare by both private and public organizations is escalating the demand of the market. The intensity for research and development by the companies in the United States is accounted for around 17%, rise in the aging population, Y-O-Y growth in the incidence of chronic diseases, infectious and non-communicable conditions are anticipated to propel the demand of this market.The shortage of qualified scientists and difficulties in appointing experienced employees for particular projects may restrain the region's CRO services market growth. Strict regulations for the approval of the drugs and products may hinder the market.
Clinical Research Services
Phase I Clinical Research Services
Phase II Clinical Research Services
Phase III Clinical Research Services
Phase IV Clinical Research Services
Early-Phase Development Services
Discovery Studies
Chemistry, Manufacturing, & Control (CMC)
Preclinical Services
Pharmacokinetics/Pharmacodynamics (PK/PD)
Toxicology Testing Services
Other Preclinical Services
Laboratory Services
Bioanalytical Testing Services
Analytical Testing Services
Physical Characterization
Raw Material Testing
Batch-Release Testing
Stability Testing
Other Analytical Testing Services
Consulting Services
Oncology
CNS
Cardiovascular
Pharmaceutical
Biopharmaceutical
Medical Device Companies
United States
Canada
Regionally, North America held the largest share in the global market. The large share of this regional segment can be attributed to the high-quality pharmaceutical industry standards, rapid growth in the biosimilars and biologics market, a surge in demand for outsourcing of services by pharmaceutical and biopharmaceutical companies, and a rise in the number of clinical trials in this region. Furthermore, the U.S. government's massive investment in R & D of medical care is further expected to boost the market.
The North American Contract Research Organization (CRO) Services Market is mainly dominated by companies such as Quintiles Transnational Holdings Inc., Laboratory Corporation of America Holdings, Pharmaceutical Product Development, PAREXEL International Corporation, ICON Plc, PRA Health Sciences Inc., InVentiv Health Inc., Charles River Laboratories International Inc., INC Research Holdings Inc., and Wuxi PharmaTech.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region